The COVID-19 in athletes (COVA) study: a national study on cardio-pulmonary involvement of SARS-CoV-2 infection among elite athletes

Autor: Hanne Kruuse Rasmusen, Mikkel Aarøe, Christoffer Valdorff Madsen, Helga Lillian Gudmundsdottir, Kenneth Hudlebusch Mertz, Astrid Duus Mikkelsen, Christian Have Dall, Christoffer Brushøj, Jesper Løvind Andersen, Maria Helena Dominguez Vall-Lamora, Ann Bovin, S. Peter Magnusson, Jens Jakob Thune, Redi Pecini, Lars Pedersen

Publikováno v: European Clinical Respiratory Journal, Vol 10, Iss 1 (2023)

ABSTRACTBackground COVID-19 can cause cardiopulmonary involvement. Physical activity and cardiac complications can worsen prognosis, while pulmonary complications can reduce performance.Aims To determine the prevalence and clinical implications of SA

Externí odkaz: https://doaj.org/article/aae0723c4d564be18288df1d001f256a

Coronary Atherosclerosis and Aortic Valve Disease as Long-Term Sequelae of Radiation Therapy in Childhood

Autor: Majken van den Handel Vestergaard, Ann Bovin, Erik Lerkevang Grove

Publikováno v: Case Reports in Cardiology, Vol 2021 (2021)

Coronary atherosclerosis and valvular heart disease are rare, but potentially severe sequelae following mediastinal radiation therapy. We present a case of premature ischemic heart disease and severe aortic stenosis in a 40-year-old woman following r

Externí odkaz: https://doaj.org/article/6c623fe2c8c847bea4ad9a8ec54eb209

Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial

Autor: Sussie Foghmar, Kristian Korsgaard Thomsen, Karsten Tange Veien, Tomas Jernberg, Christian Torp-Pedersen, Thomas S. G. Sehested, Eva Prescott, Per Hildebrandt, Anna Meta Dyrvig Kristensen, Borja Ibanez, Ann-Dorthe Zwisler, Ann Bovin, Hans Erik Bøtker, Theis Lange, Ida Gustafsson, Svend Eggert Jensen, Michael H. Olsen, Mogens Lytken Larsen, Charlotte Cerquira, Olav W. Nielsen, Dan Atar

Publikováno v: Trials, Vol 21, Iss 1, Pp 1-11 (2020)
Kristensen, A M D, Bovin, A, Zwisler, A D, Cerquira, C, Torp-Pedersen, C, Bøtker, H E, Gustafsson, I, Veien, K T, Thomsen, K K, Olsen, M H, Larsen, M L, Nielsen, O W, Hildebrandt, P, Foghmar, S, Jensen, S E, Lange, T, Sehested, T, Jernberg, T, Atar, D, Ibanez, B & Prescott, E 2020, ' Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction : Study protocol for a randomized controlled trial ', Trials, vol. 21, no. 1, 415 . https://doi.org/10.1186/s13063-020-4214-6
Repisalud
Instituto de Salud Carlos III (ISCIII)
Trials
Kristensen, A M D, Bovin, A, Zwisler, A D, Cerquira, C, Torp-Pedersen, C, Bøtker, H E, Gustafsson, I, Veien, K T, Thomsen, K K, Olsen, M H, Larsen, M L, Nielsen, O W, Hildebrandt, P, Foghmar, S, Jensen, S E, Lange, T, Sehested, T, Jernberg, T, Atar, D, Ibanez, B & Prescott, E 2020, ' Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction : Study protocol for a randomized controlled trial ', Trials, vol. 21, 415 . https://doi.org/10.1186/s13063-020-4214-6

BackgroundTreatment with beta-blockers is currently recommended after myocardial infarction (MI). The evidence relies on trials conducted decades ago before implementation of revascularization and contemporary medical therapy or in trials enrolling p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9398f1a668d3def37b9b338c863c324
https://hdl.handle.net/20.500.12105/10356

[Adverse events with oral anticoagulants]

Autor: Ann, Bovin, Pia, Knudsen, Maja, Hellfritzsch, Erik Lerkevang, Grove

Publikováno v: Ugeskrift for laeger. 180(32)

Anticoagulant therapy is widely used for prevention and treatment of cardiovascular disease and is frequently prescribed both in primary and secondary care. In comparison to other drugs, the frequency of medication errors is high for anticoagulant th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9bad1cf0eead860a938900638dc2c537
https://pubmed.ncbi.nlm.nih.gov/30070627

Effect of tighter glycemic control on cardiac function, exercise capacity, and muscle strength in heart failure patients with type 2 diabetes: a randomized study

Autor: Niels Møller, Ann Bovin, Henrik Holm Thomsen, Henrik Wiggers, Roni Nielsen, Jan Abrahamsen, Jens Christian Refsgaard, Hans Erik Bøtker, Helene Nørrelund

Publikováno v: BMJ Open Diabetes Research & Care
Nielsen, B R R, Wiggers, H, Thomsen, H H, Bovin, A, Refsgaard, J, Abrahamsen, J, Møller, N, Bøtker, H E & Nørrelund, H 2016, ' Effect of tighter glycemic control on cardiac function, exercise capacity, and muscle strength in heart failure patients with type 2 diabetes : a randomized study ', BMJ open diabetes research & care, vol. 4, no. 1, e000202 . https://doi.org/10.1136/bmjdrc-2016-000202

OBJECTIVES: In patients with type 2 diabetes (T2D) and heart failure (HF), the optimal glycemic target is uncertain, and evidence-based data are lacking. Therefore, we performed a randomized study on the effect of optimized glycemic control on left v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c23bb7d2c720e0dc4a5879860d1b11ea
http://europepmc.org/articles/PMC4853801